Tag: MRD

An envelope is being held with a calendar and an illustration of the colon in the background, indicating a reminder for colorectal screening.

WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer

by2 Minute Medicine

October 26, 2026

Abbott reported higher recurrence sensitivity with WGS Oncodetect than WES Oncodetect after surgery for colorectal cancer in Beta-CORRECT.

Significant reduction in prostate screening rates after revised guidelines

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

byDaniel Goldshteinand1 others

April 28, 2025

1. ctDNA detection was found to have a relapse HR of 2.91 in the placebo and HR 2.98 in the ...

Adding daratumumab increases progression free survival in multiple myeloma

Daratumumab linked to improved progression-free survival and MRD-negativity in transplant-eligible myeloma patients

byVanessa Giulianoand1 others

June 24, 2024

1. Daratumumab in combination with bortezomib, thalidomide, and dexamethasone (D-VTd) as induction and consolidation therapy led to superior progression-free survival ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: MRD

WGS Oncodetect showed higher recurrence sensitivity than WES Oncodetect in colorectal cancer

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

Daratumumab linked to improved progression-free survival and MRD-negativity in transplant-eligible myeloma patients

2MM+ All Access

Look up any US clinician

Recent Reports

Get the app

The medical literature, distilled daily.

Membership benefits